Basel, Switzerland-based Novartis AG on Thursday posted a 9% jump in second-quarter net profit, citing active sales of its prescription drugs. Novartis also reaffirmed its forecast that this year sales are seen to climb at a high-single digit pace and said net and operating profit are still expected to beat a year-ago level.
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
More:
